Document:

exv10w20

 

Exhibit 10.20

IDM Pharma, Inc.

2000 Stock Plan

French Participants

Deferred Issuance Restricted Stock Bonus Agreement 

     Pursuant to the Deferred Issuance Restricted Stock Bonus Grant Notice (“Grant Notice”)
and this Deferred Issuance Restricted Stock Bonus Agreement (collectively, the “Award”) and in
consideration of your past services, IDM Pharma, Inc. (the “Company”) has awarded you a deferred
issuance restricted stock bonus under its 2000 Stock Plan (the “Plan”) for the number of shares of
the Company’s Common Stock subject to the Award as indicated in the Grant Notice. Your Award is
granted to you effective as of the Date of Grant set forth in the Grant Notice for this Award (the
"Effective Date”). Defined terms not explicitly defined in this Deferred Issuance Restricted Stock
Bonus Agreement but defined in the Plan shall have the same definitions as in the Plan.

     NOW, THEREFORE, in consideration of the mutual covenants herein contained and other good and
valuable consideration, the receipt of which is hereby acknowledged, the parties hereto do hereby
agree that the details of your Award are as follows:

     1. Vesting.

          (a) Subject to the limitations contained herein, your Award will vest in accordance with the
vesting schedule provided in the Grant Notice, provided that vesting will cease upon the
termination of your Continuous Service.

          (b) [Upon the occurrence of any of the following events, the vesting of your Award will be
accelerated as follows, provided that you remain in the Company’s Continuous Service from the
Effective Date through such applicable date: ___
For purposes of the additional vesting provided in this Section 1(b), the accelerated vesting, if
any, shall be with respect to shares scheduled to vest last in time.]

          (c) Notwithstanding anything to the contrary set forth herein or in the Grant Notice, none of
the shares subject to your Award shall vest until the shares are issuable to you in accordance with
the provisions of Section 6(a) below. However, if the issuance of your shares is delayed pursuant
to the provisions of Section 6(b) below, and your Continuous Service has not terminated, then the
shares subject to your Award shall not vest until the earlier of: (i) termination of your
Continuous Service, or (ii) the actual date of issuance of the shares to you in accordance with
Section 6(b) below.

     2. Number of Shares. The number of shares subject to your Award may be adjusted from
time to time for capitalization adjustments, as provided in the Section 12(a) of the Plan.

1

 

     3. Securities Law Compliance. You may not be issued any shares under your Award
unless the shares are either (i) then registered under the Securities Act or (ii) the Company has
determined that such issuance would be exempt from the registration requirements of the Securities
Act. Your Award must also comply with other applicable laws and regulations governing the Award,
and you will not receive such shares if the Company determines that such receipt would not be in
material compliance with such laws and regulations.

     4. Limitations on Transfer. Your Award is not transferable, except by will or by the
laws of descent and distribution. In addition to any other limitation on transfer created by
applicable securities laws, you agree not to assign, hypothecate, donate, encumber or otherwise
dispose of any interest in any of the shares of Common Stock held by you under the Award until the
shares are issued to you in accordance with Section 6 of this Agreement. After the shares have
been issued to you, you are free to assign, hypothecate, donate, encumber or otherwise dispose of
any interest in such shares provided that any such actions are in compliance with the provisions
herein and applicable securities laws.

     5. Dividends. You shall be entitled to receive payments equal to any cash dividends
and other distributions paid with respect to a corresponding number of shares covered by your
Award, provided that if any such dividends or distributions are paid in shares, the Fair Market
Value of such shares shall be converted into additional shares covered by the Award, and further
provided that such additional shares shall be subject to the same forfeiture restrictions and
restrictions on transferability as apply to the shares subject to the Award with respect to which
they relate.

     6. Date of Issuance. 

          (a) The Company will issue to you a number of shares of the Company’s Common Stock equal to
the number of vested shares subject to your Award, including any additional shares received
pursuant to Section 5 above that relate to those vested shares, on the earlier of (i) the
___(___) month anniversary of the Effective Date, (ii) the effective date of your
termination of Continuous Service.

          (b) Notwithstanding anything to the contrary set forth herein, if the date of issuance of your
shares would occur on a date during which executive officers of the Company are prohibited by
Company policy or applicable securities or exchange rules from trading the stock of the Company,
the shares shall not be issued to you until the next business date during which trading Company
shares is not prohibited.

     7. Restrictive Legends. The shares issued under your Award shall be endorsed with
appropriate legends determined by the Company.

     8. Award not a Service Contract. Your Award is not an employment or service
contract, and nothing in your Award shall be deemed to create in any way whatsoever any obligation
on your part to continue in the employ of the Company or an Affiliate, or on the part of the
Company or an Affiliate to continue your employment. In addition, nothing in your Award shall
obligate the Company or an Affiliate, their respective stockholders, boards of directors, Officers
or

2

 

Employees to continue any relationship that you might have as a Director or Consultant for the
Company or an Affiliate.

     9. Withholding Obligations.

          (a) On or before the time you receive a distribution of shares pursuant to your Award, or at
any time thereafter as requested by the Company, you hereby authorize withholding from payroll
and/or any other amounts payable to you, and otherwise agree to make adequate provision for any
sums required to satisfy the federal, state, local and foreign tax withholding obligations of the
Company or an Affiliate, if any, which arise in connection with your Award.

          (b) Unless the tax withholding obligations of the Company and/or any Affiliate are satisfied,
the Company shall have no obligation to issue a certificate for such shares of Common Stock subject
to your Award.

     10. Unsecured Obligation. Your Award is unfunded, and as a holder of an Award, you
shall be considered an unsecured creditor of the Company with respect to the Company’s obligation,
if any, to issue shares pursuant to this Agreement. You shall not have voting or any other rights
as a stockholder of the Company with respect to the shares subject to your Award until such shares
are issued to you pursuant to Section 6 of this Agreement. Upon such issuance, you will obtain
full voting and other rights as a stockholder of the Company. Nothing contained in this Agreement,
and no action taken pursuant to its provisions, shall create or be construed to create a trust of
any kind or a fiduciary relationship between you and the Company or any other person.

     11. Notices. Any notices provided for in your Award or the Plan shall be given in
writing and shall be deemed effectively given upon receipt or, in the case of notices delivered by
the Company to you, five (5) days after deposit in the United States mail, postage prepaid,
addressed to you at the last address you provided to the Company.

     12. Miscellaneous.

          (a) The rights and obligations of the Company under your Award shall be transferable to any
one or more persons or entities, and all covenants and agreements hereunder shall inure to the
benefit of, and be enforceable by the Company’s successors and assigns. Your rights and obligations
under your Award may only be assigned with the prior written consent of the Company.

          (b) You agree upon request to execute any further documents or instruments necessary or
desirable in the sole determination of the Company to carry out the purposes or intent of your
Award.

          (c) You acknowledge and agree that you have reviewed your Award in its entirety, have had an
opportunity to obtain the advice of counsel prior to executing and accepting your Award and fully
understand all provisions of your Award.

     13. Governing Plan Document. Your Award is subject to all the provisions of the
Plan, the provisions of which are hereby made a part of your Award, and is further subject to all

3

 

interpretations, amendments, rules and regulations which may from time to time be promulgated
and adopted pursuant to the Plan. In the event of any conflict between the provisions of your
Award and those of the Plan, the provisions of the Plan shall control.

     14. Severability. If all or any part of this Agreement or the Plan is declared by
any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity
shall not invalidate any portion of this Agreement or the Plan not declared to be unlawful or
invalid. Any Section of this Agreement (or part of such a Section) so declared to be unlawful or
invalid shall, if possible, be construed in a manner which will give effect to the terms of such
Section or part of a Section to the fullest extent possible while remaining lawful and valid.

     15. Effect on Other Employee Benefit Plans. The value of the Award subject to this
Agreement shall not be included as compensation, earnings, salaries, or other similar terms used
when calculating the Employee’s benefits under any employee benefit plan sponsored by the Company
or any Affiliate, except as such plan otherwise expressly provides. The Company expressly reserves
its rights to amend, modify, or terminate any of the Company’s or any Affiliate’s employee benefit
plans.

     16. Amendment. This Agreement may not be modified, amended or terminated except by
an instrument in writing, signed by you and by a duly authorized representative of the Company.
Notwithstanding the foregoing, this Agreement may be amended solely by the Board by a writing which
specifically states that it is amending this Agreement, so long as a copy of such amendment is
delivered to you, and provided that no such amendment adversely affecting your rights hereunder may
be made without your written consent. Without limiting the foregoing, the Board reserves the right
to change, by written notice to you, the provisions of this Agreement in any way it may deem
necessary or advisable to carry out the purpose of the grant as a result of any change in
applicable laws or regulations or any future law, regulation, ruling, or judicial decision,
provided that any such change shall be applicable only to rights relating to that portion of the
Award which is then subject to restrictions as provided herein.

4exv10w21

 

Exhibit 10.21

IDM PHARMA, INC.

2000 STOCK PLAN

FRENCH ANNEX STOCK OPTION AGREEMENT

(QUALIFIED STOCK OPTIONS)

     Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option
Agreement, IDM Pharma, Inc. (the “Company”) has granted you an option under the French Annex to
its 2000 Stock Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock
indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined
terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the
same definitions as in the Plan.

     The details of your option are as follows:

     1. VESTING. Subject to the limitations contained herein, your option will vest as provided in
your Grant Notice, provided that vesting will cease upon the termination of your Continuous
Service.

     2. NUMBER OF SHARES AND EXERCISE PRICE. The number of shares of Common Stock subject to your
option and your exercise price per share referenced in your Grant Notice may be adjusted from time
to time for Capitalization Adjustments, as provided in the Plan, to the extent allowed by French
law. Additionally, as provided in Section 12 of the French Annex, the Board shall make any
adjustment to the number of shares of Common Stock subject to your option and your exercise price
per share referenced in your Grant Notice in compliance with French law.

     3. METHOD OF PAYMENT. Payment of the exercise price is due in full upon exercise of all or
any part of your option. You may elect to make payment of the exercise price in cash or by check
or in any other manner permitted by your Grant Notice, which may include one or more of the
following:

          (a) In the Company’s sole discretion at the time your option is exercised and provided that at
the time of exercise the Common Stock is publicly traded and quoted regularly in The Wall Street
Journal, pursuant to a program developed under Regulation T as promulgated by the Federal Reserve
Board that, prior to the issuance of Common Stock, results in either the receipt of cash (or check)
by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to
the Company from the sales proceeds.

          (b) Provided that at the time of exercise the Common Stock is publicly traded and quoted
regularly in The Wall Street Journal, by delivery of already-owned shares of Common Stock either
that you have held for the period required to avoid a charge to the Company’s reported earnings
(generally six months) or that you did not acquire, directly or indirectly from the Company,

1

 

that are owned free and clear of any liens, claims, encumbrances or security interests, and
that are valued at Fair Market Value on the date of exercise. “Delivery” for these purposes, in
the sole discretion of the Company at the time you exercise your option, shall include delivery to
the Company of your attestation of ownership of such shares of Common Stock in a form approved by
the Company. Notwithstanding the foregoing, you may not exercise your option by tender to the
Company of Common Stock to the extent such tender would violate the provisions of any law,
regulation or agreement restricting the redemption of the Company’s stock.

          (c) Pursuant to the following deferred payment alternative:

               (i) Not less than one hundred percent (100%) of the aggregate exercise price, plus accrued
interest, shall be due four (4) years from date of exercise or, at the Company’s election, upon
termination of your Continuous Service.

               (ii) Interest shall be compounded at least annually and shall be charged at the minimum rate
of interest necessary to avoid the treatment as interest, under any applicable provisions of the
Code, of any portion of any amounts other than amounts stated to be interest under the deferred
payment arrangement.

               (iii) At any time that the Company is incorporated in Delaware, payment of the Common Stock’s
“par value,” as defined in the Delaware General Corporation Law, shall be made in cash and not by
deferred payment.

               (iv) In order to elect the deferred payment alternative, you must, as a part of your written
notice of exercise, give notice of the election of this payment alternative and, in order to secure
the payment of the deferred exercise price to the Company hereunder, if the Company so requests,
you must tender to the Company a promissory note and a security agreement covering the purchased
shares of Common Stock, both in form and substance satisfactory to the Company, or such other or
additional documentation as the Company may request.

     4. WHOLE SHARES. You may exercise your option only for whole shares of Common Stock.

     5. SECURITIES LAW COMPLIANCE. Notwithstanding anything to the contrary contained herein, you
may not exercise your option unless the shares of Common Stock issuable upon such exercise are then
registered under the Securities Act or, if such shares of Common Stock are not then so registered,
the Company has determined that such exercise and issuance would be exempt from the registration
requirements of the Securities Act. The exercise of your option must also comply with other
applicable laws and regulations governing your option, and you may not exercise your option if the
Company determines that such exercise would not be in material compliance with such laws and
regulations.

     6. TERM. The term of your option commences on the Date of Grant and expires upon the earliest
of the following:

2

 

          (a) three (3) months after the termination of your Continuous Service for any reason other
than your Disability or death, provided that if during any part of such three- (3-) month period
your option is not exercisable solely because of the condition set forth in the preceding paragraph
relating to “Securities Law Compliance,” your option shall not expire until the earlier of the
Expiration Date or until it shall have been exercisable for an aggregate period of three (3) months
after the termination of your Continuous Service;

          (b) twelve (12) months after the termination of your Continuous Service due to your
Disability;

          (c) six (6) months after your death if you die either during your Continuous Service or within
three (3) months after your Continuous Service terminates;

          (d) the Expiration Date indicated in your Grant Notice; or

          (e) the tenth (10th) anniversary of the Date of Grant.

     7. EXERCISE.

          (a) You may exercise the vested portion of your option (and the unvested portion of your
option if your Grant Notice so permits) during its term by delivering a Notice of Exercise (in a
form designated by the Company) together with the exercise price to the Secretary of the Company,
or to such other person as the Company may designate, during regular business hours, together with
such additional documents as the Company may then require.

          (b) By exercising your option you agree that, as a condition to any exercise of your option,
the Company may require you to enter into an arrangement providing for the payment by you to the
Company of any tax or employee social security charges withholding obligation of the Company
arising by reason of (1) the exercise of your option, or (2) the disposition of shares of Common
Stock acquired upon such exercise.

     8. TRANSFERABILITY. Your option is not transferable, except by will or by the laws of descent
and distribution, and is exercisable during your life only by you. Notwithstanding the foregoing,
by delivering written notice to the Company, in a form satisfactory to the Company, you may
designate a third party who, in the event of your death, shall thereafter be entitled to exercise
your option.

     9. LOCK-UP PERIOD. In the event of an exercise of your option prior to the fourth (4th)
anniversary of the date of grant (as indicated in your Grant Notice), the shares of Common Stock
received upon exercise of such option shall be held in a separate account with a Company brokerage
firm and may not be sold, assigned, donated or otherwise disposed of until the fourth (4th)
anniversary of the date of grant. This lock-up period may be extended, accelerated or reduced by
the Board.

     However, this lock-up period shall not apply if you die or become disabled (as defined under
in the second and third categories of Articles L.341-4 of the French social security code). In
addition, if you retire or are dismissed, this lock-up period shall not apply to any shares of
Common

3

 

Stock received upon exercise of your option, provided that your option was exercised at least
three months prior to the date of your retirement or dismissal. Furthermore, this lock-up period
shall not apply if you exercise your option following the termination of your Continuous Service
within the post-termination exercise period permitted by Section 6(a) above.

     10. RIGHT OF REPURCHASE. To the extent provided in the Company’s bylaws as amended from time
to time, the Company shall have the right to repurchase all or any part of the shares of Common
Stock you acquire pursuant to the exercise of your option.

     11. OPTION NOT A SERVICE CONTRACT. Your option is not an employment or service contract, and
nothing in your option shall be deemed to create in any way whatsoever any obligation on your part
to continue in the employ of the Company or an Affiliate, or of the Company or an Affiliate to
continue your employment. In addition, nothing in your option shall obligate the Company or an
Affiliate, their respective shareholders, Boards of Directors, Officers or Employees to continue
any relationship that you might have as a Director or Consultant for the Company or an Affiliate.

     12. WITHHOLDING OBLIGATIONS.

          (a) At the time you exercise your option, in whole or in part, or at any time thereafter as
requested by the Company, you hereby authorize withholding from payroll and any other amounts
payable to you, and otherwise agree to make adequate provision for (including by means of a
“cashless exercise” pursuant to a program developed under Regulation T as promulgated by the
Federal Reserve Board to the extent permitted by the Company), any sums required to satisfy any
applicable taxes and employee social security charges, if any, and/or if you have become a US
resident for tax purposes after the grant of options, federal, state, local and foreign tax
withholding obligations of the Company or an Affiliate, if any, which arise in connection with your
option.

          (b) At the time of the sale, assignment, donation or other disposition of your shares
(including a transfer from your separate brokerage account referenced in Section 9 of this Stock
Option Agreement to another account) and in compliance with any applicable conditions or
restrictions of law, you hereby authorize withholding from payroll and any other amounts payable to
you, and/or from the shares of Common Stock which are being sold, assigned, donated or otherwise
disposed of by you from your separate brokerage account referenced in Section 9 of this Stock
Option Agreement, a number of whole shares of Common Stock having a Fair Market Value, determined
by the Company as of the date of sale, not in excess of the minimum amount of any applicable taxes
and employee social security charges, if any, required to be withheld by law. Any adverse
consequences to you arising in connection with such share withholding procedure shall be your sole
responsibility.

          (c) If you are no longer a resident of France for tax purposes after the grant of options,
upon your request and subject to approval by the Company, in its sole discretion, and compliance
with any applicable conditions or restrictions of law, the Company may withhold from fully vested
shares of Common Stock otherwise issuable to you upon the exercise of your option a number of whole
shares of Common Stock having a Fair Market Value, determined by the Company as of the date of
exercise, not in excess of the minimum amount of tax required to be withheld by

4

 

law. Any adverse consequences to you arising in connection with such share withholding
procedure shall be your sole responsibility.

          (d) If you are no longer a resident of France for tax purposes after the grant of options, you
may not exercise your option unless the tax withholding obligations of the Company and/or any
Affiliate are satisfied. Accordingly, you may not be able to exercise your option when desired
even though your option is vested, and the Company shall have no obligation to issue a certificate
for such shares of Common Stock or release such shares of Common Stock from any escrow provided for
herein.

     13. NOTICES. Any notices provided for in your option or the Plan shall be given in writing
and shall be deemed effectively given upon receipt or, in the case of notices delivered by mail by
the Company to you, fifteen (15) days after deposit in the United States mail, postage prepaid,
addressed to you at the last address you provided to the Company.

     14. GOVERNING PLAN DOCUMENT. Your option is subject to all the provisions of the Plan, the
provisions of which are hereby made a part of your option, and is further subject to all
interpretations, amendments, rules and regulations which may from time to time be promulgated and
adopted pursuant to the Plan. In the event of any conflict between the provisions of your option
and those of the Plan, the provisions of the Plan shall control.

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}]]